1. Volume 68, Issue 5, Pages 2375-2380 (November 2005)
Cefazolin plus netilmicin versus cefazolin plus ceftazidime for treating CAPD peritonitis: Effect on residual renal function 
Sing Leung Lui, S.U.K.W.A.I. Cheng, Flora Ng, S.U.K.Y.I. Ng, K.I.T.M.U.I. Wan, Terence Yip, K.A.I.Chung Tse, M.A.N.F.A.I. Lam, K.A.R.Neng Lai, W.A.I.K.E.I. Lo 
Kidney International 
Volume 68, Issue 5, Pages (November 2005)
DOI: /j x
Copyright © 2005 International Society of Nephrology Terms and Conditions

2. Figure 1 Flow of patients in the study.
Kidney International  , DOI: ( /j x)
Copyright © 2005 International Society of Nephrology Terms and Conditions

3. Figure 2
Serial change in PDF total WBC count of CAPD patients with peritonitis successfully treated with i.p. cefazolin plus netilmicin or i.p. cefazolin plus ceftazidime.
Kidney International  , DOI: ( /j x)
Copyright © 2005 International Society of Nephrology Terms and Conditions

4. Figure 3
Serial change in RRF of CAPD patients with peritonitis successfully treated with i.p. cefazolin plus netilmicin or i.p. cefazolin plus ceftazidime. *P < 0.001; **P =
Kidney International  , DOI: ( /j x)
Copyright © 2005 International Society of Nephrology Terms and Conditions

5. Figure 4
Serial change in 24-hour urine volume of CAPD patients with peritonitis successfully treated with i.p. cefazolin plus netilmicin or i.p. cefazolin plus ceftazidime. *P < 0.001; **P =
Kidney International  , DOI: ( /j x)
Copyright © 2005 International Society of Nephrology Terms and Conditions